tirzepatide weight loss candidate requirements bmi criteria for GLP-1: what body mass index do you actually need to qualify How to Qualify for Mounjaro

Intensive Behavioral Therapy for Obesity opens in new window , Medicare.gov, last accessed April 24, 2026

doi: 10.1128/jvi.00685-25 492 BelkacemNSerafiniNWheelerRDerrienMBoucinhaLCouesnonAet al

Potency Test Confirmed every 3-6 months to ensure every dose stays within 10% of its target strength

Sun Pharmas approval makes South Africa its second market for the product after India and demonstrates how Indian generic manufacturers are positioning themselves to capture demand as semaglutide patents expire across major emerging economies

Moreover, some benefits on clinical and metabolic features of PCOS may not have fully emerged due to the low or medium doses employed in the vast majority of the current studies